Earlier optimisation for moderate or severe COPD: Ignite Webinar
Tuesday 9th June 2020 7:00pm – 8:00pm (AEST) Professor David Barnes, Respiratory & Sleep Medicine Physician Learning Objectives: Unmet need in COPD and consequences of late diagnosis and treatment. Treating the predominant trait: ‘Breathlessness’ or ‘Exacerbations’. The role of Trelegy (Fluticasone Furoate/Umeclidinium/Vilanterol) (ICS/LAMA/LABA) for the treatment of moderate to severe COPD and its benefits vs Multiple Inhaler Triple Therapy. Find out more and register here.
